Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population
about
Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort studyThe current status of primary prevention in coronary heart diseaseAspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trialsIndividualised multifactorial lifestyle intervention trial for high-risk cardiovascular patients in primary care.A laboratory based intervention to improve appropriateness of lipid tests and audit cholesterol lowering in primary careModelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study.Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin.Treating the patient or the population? Part 2. Judging the benefit of a treatment to society as a wholeRisk in cardiovascular disease. Merit of using risk reduction rather than absolute risk for lipid lowering drugs.National service framework for coronary heart disease. Ambiguities need to be clarifiedFamily history is important in estimating coronary risk.Atherosclerotic Cardiovascular Risk in Japan.Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study.The Framingham Heart Study's impact on global risk assessmentStatins and the prevention of coronary heart disease: striking a balance that is desirable, affordable, and achievable.The primary prevention of coronary heart disease with statins: practice headache or public health?Management of UTI in general practice: a cost effective analysis. A commentary to facilitate an understanding of economic evaluation.Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study.Doxazosin versus bendrofluazide: a comparison of the metabolic effects in British South Asians with hypertension.Low prevalence of lipid lowering drug use in older men with established coronary heart diseaseFramingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians.Cardiovascular and coronary risk estimation in hypertension managementCardiovascular risk management in primary care.Comparison of methods to identify individuals at increased risk of coronary disease from the general population.Comparative accuracy of cardiovascular risk prediction methods in primary care patientsAn adaptation of the Framingham coronary heart disease risk function to European Mediterranean areasComparative evaluation of the new Sheffield table and the modified joint British societies coronary risk prediction chart against a laboratory based risk score calculation.Health Disparity Still Exists in an Economically Well-Developed Society in Asia.Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate.The influence of hip circumference on the relationship between abdominal obesity and mortality.Novel gene-by-environment interactions: APOB and NPC1L1 variants affect the relationship between dietary and total plasma cholesterol.Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).A systematic review of the impact of including both waist and hip circumference in risk models for cardiovascular diseases, diabetes and mortality.The need for integrated primary health care to enhance the effectiveness of health services.Clustering of risk factors and social class in childhood and adulthood in British women's heart and health study: cross sectional analysisComparison of methods of estimating coronary risk. Authors did not use latest version of Sheffield table.Guidelines on preventing cardiovascular disease in clinical practice.Statins: underused by those who would benefitReproducibility of individualized coronary heart disease risk calculations in patients with diabetes mellitus.What cause of mortality can we predict by cholesterol screening in the Japanese general population?
P2860
Q24630111-A6ACB58C-3D35-46F0-8FB2-F8B627CF1F90Q24793532-4F5392C6-782E-4D99-9340-53F565D5F55CQ28175861-E327D12C-E035-4769-9561-29228E4F7FFBQ28344269-248ED85A-1FE5-4A7F-B458-410A88B01D8FQ28364777-2EFE2CD5-0FC7-46BA-96CC-2218D682B40EQ30762470-485368F1-A3EC-4EE6-AD23-EECD3B33FBE8Q30949259-835199B6-463A-4A0E-A037-C57BA06C58C3Q33729189-994E000B-185B-4398-80FC-691417EB16CFQ33801256-D51CD05C-462F-461A-83D0-E78F71A9F384Q33801877-8B940DCC-09D6-4CD6-A81F-4333C30958EFQ33817978-3335A04C-B33F-4739-950F-C74B3099A24EQ33825407-DE796E9C-A3AD-4DF6-A92A-84A5FA1EC9DEQ33953825-A4F02797-8A5F-4BE3-AEB1-8890F22B5332Q33996738-F5918173-1C5C-4A93-A5BD-C05ACFF430D3Q34219006-1104D30C-FA84-4156-A681-68E9F6BADF36Q34219017-95807105-A2A4-43EA-926B-4A1C477D5EC1Q34219027-330091F9-0FA8-449D-9BF7-E20951DBDA59Q34360730-8BBBD837-EBEA-4E7A-9C83-B1C21EC9D734Q34652730-D1335EAD-E8F3-4DBF-AABD-3F6CCF797C08Q34688759-2D332FDA-854C-48EA-BB17-61D1FF8A56E1Q34742666-64F22E46-23EB-4681-AD4E-5E5889A588C4Q34786283-2EA8E7B3-13C4-4700-81B3-ED159C616090Q34983294-44C724A6-A0EE-4AF9-9948-CE74468CC2F4Q35107952-43D6EABE-6AE8-45FB-A54E-EAD267B16445Q35377637-F5B29156-094F-4590-AE6E-70DD75243AF2Q35412825-94AB36E7-87C0-430B-84D6-75A8FCA212FEQ35514010-F83E95D2-C088-4C9A-9464-4AFD1559AF7EQ35670907-71A603F0-1950-4CD8-9BDD-986529C90D71Q35788919-8D6BBC8D-132A-40F8-815A-2BDF3D65DA90Q35883636-C1E089EC-6D94-4DE7-A585-9F3239BF1137Q36754862-0F7A7D8D-1A4E-4366-97A8-9CA6CD70E36CQ37488452-3C52D2CF-2D11-4369-A86A-4914E956B687Q38052579-5E14D27F-A188-4358-A578-818C83A4D964Q40549302-5D9872AF-0244-431D-859C-08F941F6A0E3Q40762277-342B16F0-1C26-488A-8E48-24E56CDD582BQ42122799-04543997-F0BC-4B1A-A31B-2568A07C79A4Q42766542-BDE561B0-3B80-41E9-9C8D-F30D8FA44ECCQ42768879-641D040F-6752-4CBA-86B9-E44A63190690Q44024479-98A156CE-C3E6-462D-936C-C95CBF3BB462Q44287728-61998ED4-E007-4263-8498-CB13C27B12F9
P2860
Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Coronary and cardiovascular ri ...... ttish health survey population
@en
Coronary and cardiovascular ri ...... tish health survey population.
@nl
type
label
Coronary and cardiovascular ri ...... ttish health survey population
@en
Coronary and cardiovascular ri ...... tish health survey population.
@nl
prefLabel
Coronary and cardiovascular ri ...... ttish health survey population
@en
Coronary and cardiovascular ri ...... tish health survey population.
@nl
P2093
P2860
P356
P1433
P1476
Coronary and cardiovascular ri ...... ttish health survey population
@en
P2093
E J Wallis
K Rowland-Yeo
L E Ramsay
P Ghahramani
P R Jackson
P2860
P304
P356
10.1136/BMJ.320.7236.671
P407
P577
2000-03-01T00:00:00Z